Want to see ALGS full AI Analyst Report?
Aligos Therapeutics (ALGS) Q1 2026 Earnings Report
ALGS Q1 2026 EPS Results
- Actual EPS
- -$2.21
- Consensus EPS
- -$2.21
- Beat/Miss
- Beat by +$0.00
- One Year Ago EPS
- -$2.11
ALGS Q1 2026 Revenue Results
- Actual Revenue
- $2.83M
- Expected Revenue
- $250.00K
- Beat/Miss
- Beat by +$2.58M
- YoY Revenue Growth
- +809.97%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/07/2026
- Time
- After Close
- Conference Call
- Thursday, May 7, 2026
ALGS Upcoming Earnings
Aligos Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
ALGS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | ―- | -1.91 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -1.09-0.14 | -1.53 | 90.85% (+1.39) | |
| May 07, 2026 | 2026 (Q1) | -2.21-2.21 | -2.11 | -4.74% (-0.10) | |
| Mar 05, 2026 | 2025 (Q4) | -2.49-1.91 | -13.08 | 85.40% (+11.17) | |
| Nov 06, 2025 | 2025 (Q3) | -1.90-3.04 | -3.07 | 0.98% (+0.03) | |
| Aug 06, 2025 | 2025 (Q2) | -2.36-1.53 | 0.75 | -304.00% (-2.28) | |
| May 06, 2025 | 2025 (Q1) | -2.98-2.11 | -5.5 | 61.64% (+3.39) | |
| Mar 10, 2025 | 2024 (Q4) | -2.50-13.08 | -5.5 | -137.82% (-7.58) | |
| Nov 06, 2024 | 2024 (Q3) | -2.16-3.07 | -10.25 | 70.05% (+7.18) | |
| Aug 06, 2024 | 2024 (Q2) | -4.000.75 | -10.75 | 106.98% (+11.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
